Cancer Treatment Centers of America
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.

The CTCA blog

Steer clear of agave? Why stevia may be a better choice


Health-conscious people who are searching for a natural sweetener have probably come across agave nectar. In recent years, agave has been touted as a natural sugar substitute that can be added to beverages, baked goods and other foods in need of a sweet boost.

FDA should grant accelerated approval for ovarian cancer drug

Maurie Markman, MD

Symptoms of ovarian cancer—nausea, bloating and pelvic pain—are so general that they are often confused with less serious conditions. As a result, the majority of women are diagnosed when the disease already has reached an advanced stage, making it more difficult to treat effectively. Oncologists, and the women they treat, are eager for new therapies to help extend the lives of women with advanced ovarian cancer.

Chicago Bears and CTCA team up to raise prostate cancer awareness


CTCA and the Chicago Bears have teamed up to raise awareness about the second most common cancer among men in the United States: prostate cancer. The American Cancer Society estimates 233,000 men will be diagnosed with prostate cancer this year, and about one in seven men will develop the disease in their lifetime. Together, CTCA and the Bears hope to open up dialogue about prostate cancer and encourage men to make strides to lower their risk for the disease.

The soy debate: Is soy good for you?


The debate over the pros and cons of soy has been gaining momentum in recent years, with some touting the benefits of soy and others vehemently against the versatile bean. With all the misinformation out there, we asked Carolyn Lammersfeld, Vice President of Integrative Medicine at our Chicago-area hospital, to chime in.

$109 million pledged during Stand Up to Cancer fundraiser


Stand Up to Cancer called on some of the biggest names in Hollywood for its fundraising telecast on Sept. 5 and brought in more than $109 million in pledges for cancer research. CTCA was one of four “Visionary” donors supporting the event.

The fundraiser kicked off on the red carpet at the Dolby Theatre in Los Angeles and lasted through the evening.